SP-6616

N/A

Report date: 2022/01/07 18:00:53
NME

Base Information

Drug NameSP-6616
Drug Alias NameSP-6616
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPotassium voltage-gated channel subfamily B member 1 inhibitors
TargetsPotassium voltage-gated channel subfamily B member 1
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShanghai Institute Of Materia Medica, Chinese Academy Of Sciences
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Institute Of Materia Medica, Chinese Academy Of Sciences
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A